Trial Profile
Observation study for availability of phone support service for management of Capecitabine in patients with Colorectal Cancer(XTRA study)
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2012
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- Acronyms XTRA
- 10 May 2012 New trial record